LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Intravitreal Clindamycin as an Adjuvant Therapy in Congenital Toxoplasma Retinochoroiditis in a Neonate - A Case Report.

Photo by finnnyc from unsplash

PURPOSE To report a case of active retinochoroiditis in a neonate treated with intravitreal clindamycin as an adjuvant therapy. CASE REPORT A 10-day-old infant presented with active retinochoroiditis lesions in… Click to show full abstract

PURPOSE To report a case of active retinochoroiditis in a neonate treated with intravitreal clindamycin as an adjuvant therapy. CASE REPORT A 10-day-old infant presented with active retinochoroiditis lesions in both eyes along with hepatosplenomegaly, abdominal distension, and thrombocytopenia. The mother had a history of fever in the third trimester for which she received symptomatic treatment. The infant was treated with systemic anti-toxoplasma therapy along with intravitreal clindamycin in the severely affected eye. There was a significant faster resolution in the retinochoroiditis lesions, which eventually lead to better anatomical and visual outcomes. CONCLUSION AND IMPORTANCE Active screening and timely intervention of the neonates who are born to mothers with fever during pregnancy can go a long way in preventing unlikely outcomes due to congenital toxoplasma retinochoroiditis. Intravitreal clindamycin can be considered as an adjuvant therapy in selected cases.

Keywords: report; adjuvant therapy; intravitreal clindamycin; retinochoroiditis

Journal Title: Ocular immunology and inflammation
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.